GlassScriptPhysician profile
Jordan H Bailey
NPI 1750507372
$10,001.38
in general payments reported to CMS, 2019-2025
50 companies · $2,033 in 2025
The $2,033 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,211 · 2022: $2,033 · 2023: $2,035 · 2024: $1,689 · 2025: $2,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,756.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,969.42 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,021.75 | 2021-2025 | Farxiga, Breztri, Tezspire |
| Lilly USA, LLC | $957.89 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $578.53 | 2021-2025 | |
| Amgen INC. | $547.57 | 2021-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $519.68 | 2022-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $380.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $321.40 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $309.94 | 2021-2025 | Trintellix |
| Corium, LLC | $259.30 | 2022-2023 | Azstarys |
| Eisai INC. | $238.93 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $228.52 | 2023-2025 | Caplyta |
| Esperion Therapeutics, INC. | $223.57 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $219.13 | 2021 | |
| Upsher-Smith Laboratories LLC | $208.75 | 2021-2022 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $198.96 | 2021-2022 | |
| Lundbeck LLC | $185.91 | 2022-2025 | Rexulti, Vyepti |
| Exact Sciences Corporation | $157.04 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vanda Pharmaceuticals INC. | $149.95 | 2024-2025 | Fanapt, Hetlioz |
| Glaxosmithkline, LLC. | $118.95 | 2021-2025 | Shingrix, Arexvy |
| Teva Pharmaceuticals USA, INC. | $110.83 | 2021-2024 | Ajovy |
| Axsome Therapeutics, INC. | $99.45 | 2022-2025 | Auvelity, Symbravo |
| Tms Neurohealth Centers INC. | $97.28 | 2025 | Tms Neurohealth Centers INC. |
| Qorumpartners | $81.17 | 2022 | |
| Idorsia Pharmaceuticals US INC | $74.83 | 2022-2023 | Quviviq |
| Astellas Pharma US INC | $66.21 | 2023-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $64.07 | 2021-2022 | |
| Coala Life INC | $58.77 | 2023 | Coala Heart Monitor |
| Alk-Abello, INC | $53.14 | 2023-2024 | Grastek, Odactra, Ragwitek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.55 | 2021-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $49.76 | 2025 | Rexulti |
| Viatris Specialty LLC | $37.33 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $35.52 | 2024 | Opsumit, Uptravi |
| Kowa Pharmaceuticals America, INC. | $31.58 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.10 | 2024-2025 | |
| Sanofi Pasteur INC. | $28.14 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $25.24 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $23.66 | 2024 | |
| Becton, Dickinson and Company | $22.83 | 2025 | Bd Max System, Bd Max Instrument |
| Sumitomo Pharma America, INC. | $19.99 | 2024 | Gemtesa |
| Kaleo, INC. | $18.99 | 2021 | |
| Abbott Laboratories | $16.95 | 2022 | |
| Inspire Medical Systems, INC. | $16.43 | 2023 | Inspire |
| Neos Therapeutics, LP | $15.89 | 2024 | Adzenys Xr-Odt |
| Mylan Specialty L.P. | $14.52 | 2022 | |
| Merck Sharp & Dohme LLC | $13.63 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.49 | 2025 | Unithroid |
| Genentech USA, INC. | $11.82 | 2021 | |
| Adlon Therapeutics L.P. | $11.48 | 2021 | |
| Horizon Therapeutics Plc | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.